Spliceosome Mutations Are Frequent In Patients With Myelodysplastic Syndromes Who Failed Hypomethylating Therapy: Possible Implications Of Spliceosome Inhibitors As Alternative Treatments

Autor: Visconte, Valeria *, Traina, Fabiola, Tabarroki, Ali *, Hasrouni, Edy *, Ai, Jing, Kalaycio, Matt, Advani, Anjali S., Duong, Hien K., Saunthararajah, Yogen, Barnard, John *, Sekeres, Mikkael A., Tiu, Ramon V.
Zdroj: In Blood 15 November 2013 122(21):5237-5237
Databáze: ScienceDirect